889 related articles for article (PubMed ID: 34153517)
1. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.
Greenhawt M; Abrams EM; Shaker M; Chu DK; Khan D; Akin C; Alqurashi W; Arkwright P; Baldwin JL; Ben-Shoshan M; Bernstein J; Bingemann T; Blumchen K; Byrne A; Bognanni A; Campbell D; Campbell R; Chagla Z; Chan ES; Chan J; Comberiati P; Dribin TE; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Grayson MH; Horner CC; Hourihane J; Katelaris CH; Kim H; Kelso JM; Lang D; Ledford D; Levin M; Lieberman J; Loh R; Mack D; Mazer B; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Oppenheimer J; Perrett KP; Ramsey A; Rank M; Robertson K; Sheikh J; Spergel JM; Stukus D; Tang MLK; Tracy JM; Turner PJ; Whalen-Browne A; Wallace D; Wang J; Waserman S; Witry JK; Worm M; Vander Leek TK; Golden DBK
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3546-3567. PubMed ID: 34153517
[TBL] [Abstract][Full Text] [Related]
2. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.
Greenhawt M; Dribin TE; Abrams EM; Shaker M; Chu DK; Golden DBK; Akin C; Anagnostou A; ALMuhizi F; Alqurashi W; Arkwright P; Baldwin JL; Banerji A; Bégin P; Ben-Shoshan M; Bernstein J; Bingemann TA; Bindslev-Jensen C; Blumenthal K; Byrne A; Cahill J; Cameron S; Campbell D; Campbell R; Cavender M; Chan ES; Chinthrajah S; Comberiati P; Eastman JJ; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Garvey LH; Grayson MH; Isabwe GAC; Hartog N; Hendron D; Horner CC; Hourihane JO; Iglesia E; Kan M; Kaplan B; Katelaris CH; Kim H; Kelso JM; Khan DA; Lang D; Ledford D; Levin M; Lieberman JA; Loh R; Mack DP; Mazer B; Mody K; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Nathan R; Oppenheimer J; Otani IM; Park M; Pawankar R; Perrett KP; Peter J; Phillips EJ; Picard M; Pitlick M; Ramsey A; Rasmussen TH; Rathkopf MM; Reddy H; Robertson K; Rodriguez Del Rio P; Sample S; Sheshadri A; Sheik J; Sindher SB; Spergel JM; Stone CA; Stukus D; Tang MLK; Tracy JM; Turner PJ; Vander Leek TK; Wallace DV; Wang J; Wasserman S; Weldon D; Wolfson AR; Worm M; Yacoub MR
J Allergy Clin Immunol; 2023 Aug; 152(2):309-325. PubMed ID: 37295474
[TBL] [Abstract][Full Text] [Related]
3. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.
Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M
JAMA Intern Med; 2022 Apr; 182(4):376-385. PubMed ID: 35188528
[TBL] [Abstract][Full Text] [Related]
4. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A
J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination.
Karaaslan BG; Burtecene N; Mustu U; Ocak S; Kasapcopur O; Kıykım A; Cokugras H
Allergol Immunopathol (Madr); 2023; 51(3):174-180. PubMed ID: 37169575
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis.
Greenhawt M; Shaker M; Golden DBK; Abrams EM; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Chu DK; Dwamena BA
Allergy; 2023 Jan; 78(1):71-83. PubMed ID: 36321821
[TBL] [Abstract][Full Text] [Related]
7. Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of testing with PEG 1500 extract.
Gaspar A; Moura AL; Cruz C; Borrego LM
Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):261-270. PubMed ID: 36458507
[No Abstract] [Full Text] [Related]
8. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.
Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P
Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521
[TBL] [Abstract][Full Text] [Related]
9. Anaphylaxis is a rare reaction in COVID-19 vaccination.
Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 mRNA vaccine allergy.
Risma KA
Curr Opin Pediatr; 2021 Dec; 33(6):610-617. PubMed ID: 34670264
[TBL] [Abstract][Full Text] [Related]
11. Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation.
Erdeljic Turk V
Clin Immunol; 2021 Jun; 227():108748. PubMed ID: 33932618
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 and allergy - what have we learned after two and a half years?
Brockow K; Wang R; Mathes S; Bent R; Faihs V; Eberlein B; Darsow U; Biedermann T
Allergol Select; 2023; 7():101-112. PubMed ID: 37056446
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines.
Wang CW; Chen CB; Lu CW; Chen WT; Hui RC; Chiu TM; Chi MH; Lin JC; Huang YH; Chang YC; Wu J; Chen KY; Lin YY; Ger TY; Lin JY; Tsai WT; Pan YJ; Chung WH
J Autoimmun; 2023 Jul; 138():103054. PubMed ID: 37245259
[TBL] [Abstract][Full Text] [Related]
14. The Polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients.
Sellaturay P; Gurugama P; Harper V; Dymond T; Ewan P; Nasser S
Clin Exp Allergy; 2022 Jan; 52(1):12-17. PubMed ID: 34822190
[TBL] [Abstract][Full Text] [Related]
15. Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper.
Barbaud A; Garvey LH; Arcolaci A; Brockow K; Mori F; Mayorga C; Bonadonna P; Atanaskovic-Markovic M; Moral L; Zanoni G; Pagani M; Soria A; Jošt M; Caubet JC; Carmo A; Mona AA; Alvarez-Perea A; Bavbek S; Benedetta B; Bilo MB; Blanca-López N; Bogas HG; Buonomo A; Calogiuri G; Carli G; Cernadas J; Cortellini G; Celik G; Demir S; Doña I; Dursun AB; Eberlein B; Faria E; Fernandes B; Garcez T; Garcia-Nunez I; Gawlik R; Gelincik A; Gomes E; Gooi JHC; Grosber M; Gülen T; Hacard F; Hoarau C; Janson C; Johnston SL; Joerg L; Kepil Özdemir S; Klimek L; Košnik M; Kowalski ML; Kuyucu S; Kvedariene V; Laguna JJ; Lombardo C; Marinho S; Merk H; Meucci E; Morisset M; Munoz-Cano R; Murzilli F; Nakonechna A; Popescu FD; Porebski G; Radice A; Regateiro FS; Röckmann H; Romano A; Sargur R; Sastre J; Scherer Hofmeier K; Sedláčková L; Sobotkova M; Terreehorst I; Treudler R; Walusiak-Skorupa J; Wedi B; Wöhrl S; Zidarn M; Zuberbier T; Agache I; Torres MJ
Allergy; 2022 Aug; 77(8):2292-2312. PubMed ID: 35112371
[TBL] [Abstract][Full Text] [Related]
16. mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.
Banerji A; Wickner PG; Saff R; Stone CA; Robinson LB; Long AA; Wolfson AR; Williams P; Khan DA; Phillips E; Blumenthal KG
J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1423-1437. PubMed ID: 33388478
[TBL] [Abstract][Full Text] [Related]
17. Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: Northwell Health experience.
Kaplan B; Farzan S; Coscia G; Rosenthal DW; McInerney A; Jongco AM; Ponda P; Bonagura VR
Ann Allergy Asthma Immunol; 2022 Feb; 128(2):161-168.e1. PubMed ID: 34699968
[TBL] [Abstract][Full Text] [Related]
18. Identifying and Managing Those at Risk for Vaccine-Related Allergy and Anaphylaxis.
Stone CA; Garvey LH; Nasser S; Lever C; Triggiani M; Parente R; Phillips EJ
J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2008-2022. PubMed ID: 37182566
[TBL] [Abstract][Full Text] [Related]
19. Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy.
Inoue S; Igarashi A; Morikane K; Hachiya O; Watanabe M; Kakehata S; Sato S; Ueno Y
Respir Investig; 2022 Mar; 60(2):248-255. PubMed ID: 34920980
[TBL] [Abstract][Full Text] [Related]
20. The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis.
Shaker M; Phillips E; Blumenthal KG; Abrams EM; Banerji A; Oppenheimer J; Vander Leek TK; Mack DP; Wickner PG; Singer AG; Khan DA; Greenhawt M
J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2556-2561. PubMed ID: 33892171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
